MRI for Assessing Prostate Cancer Response

Launched by SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER AT JOHNS HOPKINS · May 25, 2012

Keywords

ClinConnect Summary

This clinical trial is exploring how advanced MRI techniques can help doctors see how well prostate cancer treatments, specifically radiation therapy, are working. Prostate cancer affects many men and while radiation therapy can be effective, it can also harm nearby healthy tissues. This study aims to use special MRI scans during and after radiation treatment to track changes in the tumor and surrounding tissues. By doing this, doctors hope to catch any problems early, allowing for quicker interventions that might protect healthy organs and improve treatment outcomes.

To participate in this study, men aged 65 to 74 who have been diagnosed with prostate cancer and plan to receive radiation therapy may be eligible. However, some individuals cannot participate, including those who have certain medical devices like pacemakers, are allergic to specific MRI contrast agents, or have chronic kidney issues. Those who join the study will undergo advanced MRI scans to help doctors understand how the cancer is responding to treatment and to assess any potential side effects. This research is important because it could lead to better monitoring of prostate cancer treatment and improved care for patients.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Histologically-confirmed prostate cancer
• • Plan to undergo external radiation treatment of prostate cancer
• Exclusion Criteria:
• • Patients who cannot undergo an MRIs
• • Patients who are allergic to gadolinium based contrast agent
• • Patients who have cardiac pacemaker or other electronic or metal implant
• • Patients who have chronic kidney disease